<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">Blood dyscrasias</z:e>, although rare, can be fatal </plain></SENT>
<SENT sid="1" pm="."><plain>Many drugs, including antibiotics, are associated with these <z:e sem="disease" ids="C0334044" disease_type="Neoplastic Process" abbrv="">dyscrasias</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We conducted a cohort study with a nested case-control analysis using data from the General Practice Research Database to estimate incidence rates of clinical <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">blood dyscrasias</z:e> in the general population and to examine their association with use of antibiotic drugs </plain></SENT>
<SENT sid="3" pm="."><plain>The study population consisted of patients aged 5-69 years receiving at least one antibiotic prescription from January 1994-September 1998 </plain></SENT>
<SENT sid="4" pm="."><plain>The final cohort consisted of 822,048 persons who received 1,507,307 antibiotic prescriptions during the study period </plain></SENT>
<SENT sid="5" pm="."><plain>The main outcome measure was a diagnosis of <z:hpo ids='HP_0001875'>neutropenia</z:hpo>, <z:mp ids='MP_0000334'>agranulocytosis</z:mp>, <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo>, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, bicytopenia, <z:hpo ids='HP_0001876'>pancytopenia</z:hpo>, or <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>We confirmed 122 patients who developed clinical <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">blood dyscrasias</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The incidence was 3.3/100,000 person-years in the general population </plain></SENT>
<SENT sid="8" pm="."><plain>Patients older than 60 years (relative risk [RR] 2.8, 95% confidence interval [CI] 1.6-5.0) and those who took <z:chebi fb="1" ids="37931,37932">phenothiazines</z:chebi> (RR 49.0, 95% CI 4.9-488.2) had an increased risk of <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">blood dyscrasia</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Users of antibiotics had an RR of 4.4 (95% CI 2.6-7.5), and patients taking more than one class of antibiotics had an RR of 29.1 (95% CI 9.1-92.8) </plain></SENT>
<SENT sid="10" pm="."><plain>Among individual antibiotic classes, the greatest risk was with <z:chebi fb="0" ids="23066">cephalosporins</z:chebi> (RR 13.8, 95% CI 3.6-52.6) </plain></SENT>
<SENT sid="11" pm="."><plain>Although uncommon, our study supports an association between <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">blood dyscrasias</z:e> and antibiotics </plain></SENT>
</text></document>